German biotech materials company AMSilk has appointed Christian Wichert as its new Chief Executive Officer. Wichert, who previously served as CEO of Evolva AG, brings over 25 years of leadership experience in various sectors. He will focus on scaling AMSilk’s silk protein technology and precision fermentation capabilities, particularly in the Consumer Care Solutions division.

Former CEO Ulrich Scherbel will take on the role of Chief Operating Officer for AMSilk's Premium Filaments division. Scherbel led the company through its transition to the commercial market and secured strategic partnerships. He expressed pride in the company's achievements and looks forward to continuing to develop the Premium Filament business as a key growth pillar for AMSilk. Overall, the appointment of Wichert and Scherbel's new role reflect the company's focus on commercial execution and sustainable growth.